January 27, 2026
1 min read

China regulators suspend sale of Sun Pharma’s dementia med after site inspection

China’s National Medical Products Administration suspended the import, sale and use of Sun’s rivastigmine hydrogen tartrate capsules after a virtual site inspection uncovered manufacturing shortfalls.

Leave a Reply

Your email address will not be published.

Previous Story

Grandparenting Good For The Aging Brain, Study Finds MedNews

Next Story

Top Health News: Technology, Mental Health and More

Previous Story

Grandparenting Good For The Aging Brain, Study Finds MedNews

Next Story

Top Health News: Technology, Mental Health and More

Latest from Blog

Go toTop